Published in J Hepatol on May 01, 1998
Treatment of Recurrent Hepatitis C After Liver Transplantation (TRANSPEG) | NCT00151580
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut (2002) 1.65
Hepatitis C and liver transplantation. Gut (1999) 1.03
Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation. Dig Dis Sci (2010) 0.83
Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation. Virology (2010) 0.82
A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation. Surg Today (2013) 0.82
Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity. Clin Dev Immunol (2013) 0.78
Liver transplantation for hepatitis C virus related liver disease. Postgrad Med J (2005) 0.76
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection. Clin Mol Hepatol (2016) 0.75
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature (2001) 7.06
Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell (1995) 4.70
Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis (2002) 3.04
HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60
The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant (2010) 2.40
Hepatic Encephalopathy. Am J Gastroenterol (2001) 2.37
Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene (1996) 2.20
Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Aliment Pharmacol Ther (2014) 2.17
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA (1999) 2.16
Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology (2002) 2.16
MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol (2008) 2.14
Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. J Exp Med (1997) 2.13
[A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome]. Rev Esp Enferm Dig (1991) 1.94
Pulmonary infection with Nocardia species: a report of 10 cases and review. Eur Respir J (1997) 1.83
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol (2001) 1.83
Insertional mutagenesis in the extreme thermophilic eubacteria Thermus thermophilus HB8. Mol Microbiol (1992) 1.81
Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology (2004) 1.77
High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology (1999) 1.76
Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology (2000) 1.72
Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. Am J Transplant (2008) 1.70
In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrob Agents Chemother (1992) 1.64
Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol Cell Biol (1993) 1.62
Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc Natl Acad Sci U S A (2003) 1.60
Macrodactyly: report of eight cases and review of the literature. Pediatr Dermatol (2000) 1.59
Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. Oncogene (1994) 1.59
Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans. Antimicrob Agents Chemother (1996) 1.58
Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J Virol (1990) 1.52
International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother (1983) 1.52
A conserved motif in S-layer proteins is involved in peptidoglycan binding in Thermus thermophilus. J Bacteriol (1996) 1.50
Fluid-fluid membrane microheterogeneity: a fluorescence resonance energy transfer study. Biophys J (2001) 1.47
Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg (1997) 1.46
A high-transformation-efficiency cloning vector for Thermus thermophilus. Plasmid (1999) 1.40
Onychomadesis outbreak in Valencia, Spain, June 2008. Euro Surveill (2008) 1.39
Motor pattern of the sphincter of Oddi in patients with bilioenteric shunt: a manometric study. Am J Gastroenterol (1988) 1.39
[HIV related Foix-Chavany-Marie syndrome]. Neurologia (2003) 1.39
[Correlation between magnetic resonance and disability scales (EDSS and ISS) in multiple sclerosis]. Neurologia (1991) 1.39
Response to treatment with interferon-alfa in patients with chronic hepatitis C and high titers of -M2, -M4 and -M8 antimitochondrial antibodies. Rev Esp Enferm Dig (1999) 1.39
B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching. J Immunol (1997) 1.38
[Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease]. Rev Esp Enferm Dig (1995) 1.38
[Bacteremias not detected by BACTEC NR 730]. Enferm Infecc Microbiol Clin (1990) 1.38
Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man. Dig Dis Sci (1992) 1.38
Receiver operating characteristics curve analysis of factors predictive of nonresponse to interferon therapy in patients with chronic hepatitis C. Rev Esp Enferm Dig (2000) 1.37
Secretion and assembly of regular surface structures in Gram-negative bacteria. FEMS Microbiol Rev (2000) 1.35
Development of Thermus-Escherichia shuttle vectors and their use for expression of the Clostridium thermocellum celA gene in Thermus thermophilus. J Bacteriol (1992) 1.34
In vitro activity of ciprofloxacin against Brucella melitensis. Eur J Clin Microbiol (1984) 1.33
Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J Exp Med (1994) 1.33
Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood (1998) 1.33
Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl (2001) 1.31
Resonance energy transfer in a model system of membranes: application to gel and liquid crystalline phases. Biophys J (1996) 1.31
Sequence of the S-layer gene of Thermus thermophilus HB8 and functionality of its promoter in Escherichia coli. J Bacteriol (1992) 1.31
A thermophilic nitrate reductase is responsible for the strain specific anaerobic growth of Thermus thermophilus HB8. Biochim Biophys Acta (1998) 1.29
Anaerobic growth, a property horizontally transferred by an Hfr-like mechanism among extreme thermophiles. J Bacteriol (1998) 1.27
Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis (2005) 1.26
Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactams. Antimicrob Agents Chemother (1990) 1.25
Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology (2002) 1.25
Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int (2006) 1.23
Liver transplantation in patients with portal vein thrombosis. Liver Transpl (2001) 1.23
De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl (2001) 1.22
Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther (2007) 1.21
Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam. Antimicrob Agents Chemother (1982) 1.20
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis. Antimicrob Agents Chemother (1994) 1.20
Partition of membrane probes in a gel/fluid two-component lipid system: a fluorescence resonance energy transfer study. Biochim Biophys Acta (2000) 1.19
Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation (2006) 1.19
Binding of 125I-labeled beta-lactam antibiotics to the penicillin binding proteins of Escherichia coli. J Antibiot (Tokyo) (1984) 1.18
The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis. Transplantation (1996) 1.17
Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods. J Clin Microbiol (1999) 1.17
Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen (2012) 1.16
Cloning and expression in Escherichia coli of the structural gene coding for the monomeric protein of the S layer of Thermus thermophilus HB8. J Bacteriol (1991) 1.16
Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) (1997) 1.16
Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig (1998) 1.14
Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia. Am J Respir Crit Care Med (1999) 1.13
Developmental expression of the vav protooncogene. Cell Growth Differ (1993) 1.13
Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice. Semin Cancer Biol (1997) 1.12
False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen (2012) 1.11